have reported that S100A2 activated the PI3K/AKT signaling pathway and upregulated GLUT1 expression in colorectal cancer, which induced glycolytic reprogramming and consequently increased tumor proliferation (54). This evidence concerns the gene S100A2 and colorectal cancer.